clinical trials

EURINE-ACT - EURINE-ACT is an international prospective study that examines the diagnostic and prognostic value of urine steroidobolomics in patients with adrenocortical tumours.

ADIUVO - The ADIUVO study is a prospective, randomized, open-label, controlled, international, phase III trial for patients with ACC after radical resection.

FIRST-MAPP This trial is a randomized, double-blind, phase II, international, multicenter study which is dedicated to determine the efficacy of Sunitinib on the progression-free survival at 12 months in patients with progressive malignant pheochromocytoma and paraganglioma

PMT3 - is an international multicenter prospective study of biomarkers for prediction of malignancy and hereditary pheochromocytoma and paragliomas (PPGLs).